Raymond James Reiterates “Buy” Rating for Knight Therapeutics (KHTRF)  XNewsPress

Raymond James reiterated their buy rating on shares of Knight Therapeutics (OTCMKTS:KHTRF) in a research report released on Wednesday morning. Shares …